Literature DB >> 2596677

Failure of intravenous infusions from extravasation and phlebitis.

J F Hecker1.   

Abstract

A survey was done to compare the rates at which phlebitis and extravasation cause failure of intravenous infusions lasting more than 24 hours. Slightly more infusions failed due to phlebitis than to extravasation but extravasation did not occur earlier or later than phlebitis or differ significantly from it in frequency when different types of infusions were compared. Univariate life table analysis indicated that the co-infusion of blood, potassium or cephalosporin antibiotics slightly increased and that higher flow rates markedly increased failure, that infusions including continuous heparin and steroids had markedly decreased failure, and that failure was not significantly affected by other antibiotics or by differences in sex, age, location of infusion site or time of year. Multivariate analysis showed that the above differences were statistically significant only for infusion rate, heparin and steroids.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596677     DOI: 10.1177/0310057X8901700406

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  4 in total

1.  Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion.

Authors:  C A Owens; P G Ambrose; R Quintiliani; C H Nightingale; D P Nicolau
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

2.  Influence of fine-bore catheter length on infusion thrombophlebitis in peripheral intravenous nutrition: a randomised controlled trial.

Authors:  N J Everitt; M J McMahon
Journal:  Ann R Coll Surg Engl       Date:  1997-05       Impact factor: 1.891

3.  Survival of intravenous chemotherapy infusion sites.

Authors:  J F Hecker
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

Review 4.  Infusion phlebitis assessment measures: a systematic review.

Authors:  Gillian Ray-Barruel; Denise F Polit; Jenny E Murfield; Claire M Rickard
Journal:  J Eval Clin Pract       Date:  2014-01-08       Impact factor: 2.431

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.